There has been plenty of analysis detailing how neither Washington nor Brussels has a monopoly on the imposition of precaution in product risk assessments – the problem is the disparate application by the two parties. GMO Opt-Out Trouble The EU executive thought allowing individual member states to opt out from using any approved GMOs would solve problems with the current approval process. However, members of the European Parliament have signaled the plan will not work. Opposition came from several angles, including the lack of an impact analysis, the fragmentation of the common market and a demand that GMOs simply be rejected for all of Europe if there was a simple majority against them. The proposal is now off the table for the time bei...